AKT1 and metabolic dysfunction-associated steatotic liver disease: Accordingly, we hypothesize that the phosphorylation of Akt, translocation of Nrf2, and subsequent modulation of HO-1 expression were considered as the important molecular targets for therapeutic intervention for NAFLD [10].